Murrayb Stein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murrayb stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murrayb Stein Today - Breaking & Trending Today

New Study Links Excess Cannabis Use to Numerous Health Problems

A comprehensive study conducted by researchers from Yale, involving the analysis of over one million individuals' genomes, has provided new insights into the biology of cannabis use disorder. This study also explores its connections to various psychiatric conditions, the tendency to abuse other subs ....

United States , Kellym Harrington , Todd Lencz , Frankr Wendt , J Michael Gaziano , Renato Polimanti , Yairaz Nunez , Josephd Deak , Joel Gelernter , Howardj Edenberg , Megan Cooke , Priya Gupta , Davidm Hougaard , Danielf Levey , Dora Koller , Emmac Johnson , Murrayb Stein , Michaels Helfenbein , Michaelj Gandal , Henryr Kranzler , Veeram Rajagopal , Rachel Quaden , Ditte Demontis , Marco Galimberti , Daniel Levey , Arpana Agrawal ,

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints showed improvements in depressive symptoms and sleep. BNC210 was well-tolerated with a safety profile supporting chronic administration. Company plans to engage with the U.S. Food and Drug Administration (FDA) to discuss the registrational path for BNC210 in PTSD. Webcast and conference call was held 28 September 2023 at 8:00 AM EST (10:00 PM AEST). Please click on the link to watch the replay: https://lifescievents.com/event/bnox/ ADELAIDE, Australia, and CAMBRIDGE, Mass., Sept. 29, 2023 /PRNewswire/ Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced pos ....

San Diego , United States , United Kingdom , University Of California San Diego , South Australia , Spyros Papapetropoulos , Murrayb Stein , Prnewswire Bionomics Limited Nasdaq , Merck Co Inc , Affairs San Diego Healthcare System , Bionomics Or Company , Public Health , Drug Administration , Montgomery Sberg Depression Rating Scale , Insomnia Severity Index , Sheehan Disability Scale , Distinguished Professor , California San Diego , Staff Psychiatrist , Veteran Affairs San Diego Healthcare System , Hamilton Anxiety Rating Scale , Montgomery Asberg Depression Rating Scale , Clinician Global Impression , Patient Global Impression , Traumatic Stress Disorder , Social Anxiety Disorder ,